中文
FROM CRITICAL EQUIPMENT TO
TOTAL PROCESS SOLUTION
Spring Arrives in March, Gather Again in Suzhou | Morimatsu Invites You to Attend BIOCHINA 2025 to Discuss Innovation and Collaboration in Biopharmaceuticals
Time:2025-03-20 10:30:45

BIOCHINA 2025
The 10th E-commerce Biotech Industry Exhibition

-Innovation without Boundaries, Collaboration for Symbiosis-


BIOCHINA 2025 will be held at the Suzhou International Expo Center from March 13-15. Adhering to the concept of "Innovation without Boundaries, Collaboration for Symbiosis", the event will connect five exhibition halls with ten popular tracks. Through professional exhibitions, technical forums, brainstorming sessions, product displays, new product launches, and other forms, it will empower industry technical talents with practical content.

Gathering 850 speakers
30,000+ audience
50,000+ exhibition area


Exhibition Details

Exhibition Time
March 13-15

Exhibition Venue
Suzhou International Expo Center

Morimatsu Booth
C1 Pharmaceutical Equipment Hall 142-143

Booth Renderings

As a global leader in the life science field, providing "core equipment + value-added services + digital intelligence integrated plant solutions and services", Morimatsu has always been deeply involved in technological innovation and product research and development, closely grasping the pulse of changes in the cutting-edge fields of global biopharmaceutical field.

Exhibition Highlights

At this exhibition, Morimatsu will present a full range of solutions in laboratory equipment, single-use systems, modular plants, and the digital intelligence field, bringing everyone a fascinating feast.

1.Total Laboratory Solution
This solution includes upstream culture solutions and downstream separation and purification solutions to help users accelerate the research and development process.
· Glass Bioreactor
· Stainless Steel Benchtop Tangential Flow Filtration System
· Intelligent Microfluidic Synthesizer

2.Single-Use Solution
Morimatsu's single-use systems come in various specifications compatible with multiple brands of equipment, featuring stable product processes and supported by abundant validation documents.

3.Pharmadule Morimatsu's Integrated Plant Solutions
Flexible one-stop modular solutions ensure efficient project progress and exceptional quality.

4.Morimatsu Virtual Factory Digital Twin System
It is the digital intelligence achievement of Morimatsu, helping biopharmaceutical factories achieve lean construction and manufacturing operations.

Morimatsu sincerely invites you to participate in this industry event and witness our innovative strength. We look forward to discussing forward-looking technologies with you, exploring cooperation opportunities, and jointly promoting the future development of the biopharmaceutical industry.


About Morimatsu LifeSciences

Morimatsu LifeSciences, one of the key business segments of Morimatsu International Holding Co., Ltd. (Morimatsu International, stock code: 2155.HK), mainly consists of Shanghai Morimatsu Pharmaceutical Equipment Engineering Co., Ltd., Morimatsu (Suzhou) Life Technology Co., Ltd., Shanghai Morimatsu Biotechnology Co., Ltd., Pharmadule Morimatsu AB (Sweden) and its subsidiaries, which serves the pharmaceuticals, bio-pharmaceutical, cosmetic medicine, FMCG (cosmetics, baby, women & home Care, health care, fabric & home care, food, beverage, nutraceuticals) and other industries, providing customers with "core equipment+value-added services+digital intelligent overall factory solutions and services" ("MVP Solutions&Services"), focusing on core equipment, stainless steel process systems, disposable process systems, consumables, laboratory solutions, digital and modular factory solutions and services. 

As a diversified multinational company, Morimatsu has opened subsidiaries or advanced manufacture plants in China, Japan, Sweden, United States, India, Italy, Singapore, and has delivered different forms of products and services to more than 40 countries and regions so far, by its global footprint of an efficient and professional team.   

Forward-Looking Statements

The information in this press release may include some forward-looking statements. Such statements are essentially susceptible to considerable risks and uncertainties. The use of "predicted", "believed", "forecast", "planned" and/or other similar words/phrases in all statements related to our company is to indicate that the statements are forward-looking ones. Our Company undertakes no obligation to constantly revise such predicted statements.

Forward-looking statements are based on our Company management's current perspectives, assumptions, expectations, estimations, predictions and understanding of future affairs at the time of the making of such statements. Such statements are not guarantees of future development and are susceptible to the impact of risks, uncertainties and other factors; some are beyond the control of our Company and unpredictable. Subject to the influence of future changes and development in our business, competition environment, political, economic, legal and social conditions, the actual outcomes may differ significantly from the information contained in the forward-looking statements.